CPDA-1
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- CPDA-1
- Generic name
- ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE
- Manufacturer
- Fenwal, Inc.
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- e41adb4e-06fb-4141-ba55-50b043f3c9da
- SPL ID
- f7b9be90-d870-40af-ae22-abf675d89784
- Version
- 7
- Effective date
- 2019-11-19
- Source export date
- 2026-11-06
- Source partition
- 6
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-11-06/5781d2d281f00c57d2634422e88d204f4ab5cf8444979f7006f538b3a4f26d3b/drug-label-0006-of-0014.json.zip
- Source manifest SHA-256
- 8dff71fbef1291eb7711013e9a3a06194930757924a8946ae3034107a98d9463
- Import run
- 20261106T075659Z
- Imported at
- 2026-11-06 08:34:03
| Harmonized routes |
|---|
| INTRAVENOUS |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | BN770420 | openfda.application_number | |
| brand name | CPDA-1 | openfda.brand_name | |
| generic name | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | openfda.generic_name | |
| manufacturer name | Fenwal, Inc. | openfda.manufacturer_name | |
| ndc | package | 0942-6322-04 | openfda.package_ndc |
| ndc | product | 0942-6322 | openfda.product_ndc |
| ndc11 | package | 00942632204 | derived:openfda.package_ndc |
| spl id | f7b9be90-d870-40af-ae22-abf675d89784 | id | |
| spl set id | e41adb4e-06fb-4141-ba55-50b043f3c9da | set_id | |
| unii | JAC85A2161 | openfda.unii | |
| unii | XF417D3PSL | openfda.unii | |
| unii | B22547B95K | openfda.unii | |
| unii | LX22YL083G | openfda.unii | |
| unii | 593YOG76RN | openfda.unii |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.